Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
European Journal of Clinical Pharmacology
|
December 8, 2009
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
Filip Josephson, Maria C H Andersson, Leo Flamholc, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 22, 2016
Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV
Birgitta Anesten, Aylin Yilmaz, Lars Hagberg, et al.
Ebiomedicine
|
June 21, 2016
Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140]
Magnus Gisslén, Richard W Price, Ulf Andreasson, et al.
Expert Review of Molecular Diagnostics
|
June 10, 2017
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls
Aylin Yilmaz, Kaj Blennow, Lars Hagberg, et al.
Ebiomedicine
|
February 13, 2016
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
Magnus Gisslén, Richard W Price, Ulf Andreasson, et al.
Neurology
|
October 2, 2020
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series
Arvid Edén, Nelly Kanberg, Johanna Gostner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 21, 2018
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
Magnus Gisslén, Amanda Heslegrave, Elena Veleva, et al.
Plos One
|
December 27, 2014
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection
Julia Peterson, Magnus Gisslen, Henrik Zetterberg, et al.
AIDS Research and Human Retroviruses
|
December 17, 2009
Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates
Ulf Karlsson, Liselotte Antonsson, Johanna Repits, et al.
Journal of Neuroimmunology
|
December 8, 2004
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease
Nicolai Sidenius, Manuela Nebuloni, Stefania Sala, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
European Journal of Clinical Pharmacology
|
December 8, 2009
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
Filip Josephson, Maria C H Andersson, Leo Flamholc, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 22, 2016
Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV
Birgitta Anesten, Aylin Yilmaz, Lars Hagberg, et al.
Ebiomedicine
|
June 21, 2016
Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140]
Magnus Gisslén, Richard W Price, Ulf Andreasson, et al.
Expert Review of Molecular Diagnostics
|
June 10, 2017
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls
Aylin Yilmaz, Kaj Blennow, Lars Hagberg, et al.
Ebiomedicine
|
February 13, 2016
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
Magnus Gisslén, Richard W Price, Ulf Andreasson, et al.
Neurology
|
October 2, 2020
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series
Arvid Edén, Nelly Kanberg, Johanna Gostner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 21, 2018
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
Magnus Gisslén, Amanda Heslegrave, Elena Veleva, et al.
Plos One
|
December 27, 2014
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection
Julia Peterson, Magnus Gisslen, Henrik Zetterberg, et al.
AIDS Research and Human Retroviruses
|
December 17, 2009
Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates
Ulf Karlsson, Liselotte Antonsson, Johanna Repits, et al.
Journal of Neuroimmunology
|
December 8, 2004
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease
Nicolai Sidenius, Manuela Nebuloni, Stefania Sala, et al.
Page
of 14